{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:46:14Z","timestamp":1793969174363,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19-AG068753"],"award-info":[{"award-number":["U19-AG068753"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG08122"],"award-info":[{"award-number":["AG08122"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG054076"],"award-info":[{"award-number":["AG054076"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG057902"],"award-info":[{"award-number":["AG057902"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG06234"],"award-info":[{"award-number":["AG06234"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG054156"],"award-info":[{"award-number":["RF1AG054156"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG057768"],"award-info":[{"award-number":["RF1AG057768"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG013846"],"award-info":[{"award-number":["P30AG013846"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS115266"],"award-info":[{"award-number":["U54NS115266"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS086659"],"award-info":[{"award-number":["U01NS086659"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92019D00031"],"award-info":[{"award-number":["75N92019D00031"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN2682015000011"],"award-info":[{"award-number":["HHSN2682015000011"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002466"],"award-info":[{"award-number":["BX002466"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01-CX001038"],"award-info":[{"award-number":["I01-CX001038"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX004349"],"award-info":[{"award-number":["BX004349"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nick and Lynn Buoniconti Foundation"},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-17- 529888"],"award-info":[{"award-number":["AARF-17- 529888"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease, characterized by hyperphosphorylated tau, found in individuals with a history of exposure to repetitive head impacts. While the neuropathologic hallmark of CTE is found in the cortex, hippocampal tau has proven to be an important neuropathologic feature to examine the extent of disease severity. However, the hippocampus is also heavily affected in many other tauopathies, such as Alzheimer\u2019s disease (AD). How CTE and AD differentially affect the hippocampus is unclear. Using immunofluorescent analysis, a detailed histologic characterization of 3R and 4R tau isoforms and their differential accumulation in the temporal cortex in CTE and AD was performed. CTE and AD were both observed to contain mixed 3R and 4R tau isoforms, with 4R predominating in mild disease and 3R increasing proportionally as pathological severity increased. CTE demonstrated high levels of tau in hippocampal subfields CA2 and CA3 compared to CA1. There were also low levels of tau in the subiculum compared to CA1 in CTE. In contrast, AD had higher levels of tau in CA1 and subiculum compared to CA2\/3. Direct comparison of the tau burden between AD and CTE demonstrated that CTE had higher tau densities in CA4 and CA2\/3, while AD had elevated tau in the subiculum. Amyloid beta pathology did not contribute to tau isoform levels. Finally, it was demonstrated that higher levels of 3R tau correlated to more severe extracellular tau (ghost tangles) pathology. These findings suggest that mixed 3R\/4R tauopathies begin as 4R predominant then transition to 3R predominant as pathological severity increases and ghost tangles develop. Overall, this work demonstrates that the relative deposition of tau isoforms among hippocampal subfields can aid in differential diagnosis of AD and CTE, and might help improve specificity of biomarkers for in vivo diagnosis.<\/jats:p>","DOI":"10.1186\/s40478-021-01189-4","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T07:08:03Z","timestamp":1620803283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1257-981X","authenticated-orcid":false,"given":"Jonathan D.","family":"Cherry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille D.","family":"Esnault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary H.","family":"Baucom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorghos","family":"Tripodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand R.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"1189_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-020-02197-9","volume":"140","author":"ML Alosco","year":"2020","unstructured":"Alosco ML, Cherry JD, Huber BR, Tripodis Y, Baucom Z, Kowall NW et al (2020) Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme. Acta Neuropathol 140:495\u2013512. https:\/\/doi.org\/10.1007\/s00401-020-02197-9","journal-title":"Acta Neuropathol"},{"key":"1189_CR2","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jalz.2018.05.004","volume":"14","author":"ML Alosco","year":"2018","unstructured":"Alosco ML, Tripodis Y, Fritts NG, Heslegrave A, Baugh CM, Conneely S et al (2018) Cerebrospinal fluid tau, Abeta, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration. Alzheimer\u2019s Dementia 14:1159\u20131170. https:\/\/doi.org\/10.1016\/j.jalz.2018.05.004","journal-title":"Alzheimer's Dementia"},{"key":"1189_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbadis.2004.08.010","volume":"1739","author":"A Andreadis","year":"2005","unstructured":"Andreadis A (2005) Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim Biophys Acta 1739:91\u2013103. https:\/\/doi.org\/10.1016\/j.bbadis.2004.08.010","journal-title":"Biochim Biophys Acta"},{"key":"1189_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","volume":"126","author":"T Arendt","year":"2016","unstructured":"Arendt T, Stieler JT, Holzer M (2016) Tau and tauopathies. Brain Res Bull 126:238\u2013292. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.08.018","journal-title":"Brain Res Bull"},{"key":"1189_CR5","doi-asserted-by":"publisher","first-page":"35119","DOI":"10.1074\/jbc.M505895200","volume":"280","author":"K Bhaskar","year":"2005","unstructured":"Bhaskar K, Yen SH, Lee G (2005) Disease-related modifications in tau affect the interaction between Fyn and Tau. J Biol Chem 280:35119\u201335125. https:\/\/doi.org\/10.1074\/jbc.M505895200","journal-title":"J Biol Chem"},{"key":"1189_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/jnen\/nlab001","volume":"80","author":"KF Bieniek","year":"2021","unstructured":"Bieniek KF, Cairns NJ, Crary JF, Dickson DW, Folkerth RD, Keene CD et al (2021) The second NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronictraumatic encephalopathy. J Neuropathol Exp Neurol 80:210\u2013219. https:\/\/doi.org\/10.1093\/jnen\/nlab001","journal-title":"J Neuropathol Exp Neurol"},{"key":"1189_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 82:239\u2013259","journal-title":"Acta Neuropathologica"},{"key":"1189_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/bpa.12867","volume":"30","author":"JD Cherry","year":"2020","unstructured":"Cherry JD, Kim SH, Stein TD, Pothast MJ, Nicks R, Meng G et al (2020) Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy. Brain Pathol 30:913\u2013925. https:\/\/doi.org\/10.1111\/bpa.12867","journal-title":"Brain Pathol"},{"key":"1189_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766. https:\/\/doi.org\/10.1007\/s00401-014-1349-0","journal-title":"Acta Neuropathol"},{"key":"1189_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-021-02264-9","volume":"141","author":"CL Croft","year":"2021","unstructured":"Croft CL, Goodwin MS, Ryu DH, Lessard CB, Tejeda G, Marrero M et al (2021) Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions. Acta Neuropathol 141:359\u2013381. https:\/\/doi.org\/10.1007\/s00401-021-02264-9","journal-title":"Acta Neuropathol"},{"key":"1189_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1046\/j.1365-2990.2003.00463.x","volume":"29","author":"R de Silva","year":"2003","unstructured":"de Silva R, Lashley T, Gibb G, Hanger D, Hope A, Reid A et al (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 29:288\u2013302. https:\/\/doi.org\/10.1046\/j.1365-2990.2003.00463.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1189_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-2008-14101","volume":"14","author":"M Espinoza","year":"2008","unstructured":"Espinoza M, de Silva R, Dickson DW, Davies P (2008) Differential incorporation of tau isoforms in Alzheimer\u2019s disease. J Alzheimers Dis 14:1\u201316","journal-title":"J Alzheimers Dis"},{"key":"1189_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R et al (2018) Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold. Nature 561:137\u2013140. https:\/\/doi.org\/10.1038\/s41586-018-0454-y","journal-title":"Nature"},{"key":"1189_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon B, Zivanov J, Zhang W, Murzin AG, Garringer HJ, Vidal R et al (2019) Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568:420\u2013423. https:\/\/doi.org\/10.1038\/s41586-019-1026-5","journal-title":"Nature"},{"key":"1189_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fnana.2019.00099","volume":"13","author":"D Furcila","year":"2019","unstructured":"Furcila D, Dominguez-Alvaro M, DeFelipe J, Alonso-Nanclares L (2019) Subregional density of neurons, neurofibrillary tangles and amyloid plaques in the hippocampus of patients with Alzheimer\u2019s disease. Front Neuroanat 13:99. https:\/\/doi.org\/10.3389\/fnana.2019.00099","journal-title":"Front Neuroanat"},{"key":"1189_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","volume":"40","author":"M Goedert","year":"2017","unstructured":"Goedert M, Eisenberg DS, Crowther RA (2017) Propagation of Tau aggregates and neurodegeneration. Annu Rev Neurosci 40:189\u2013210. https:\/\/doi.org\/10.1146\/annurev-neuro-072116-031153","journal-title":"Annu Rev Neurosci"},{"key":"1189_CR17","doi-asserted-by":"publisher","first-page":"38182","DOI":"10.1074\/jbc.M007489200","volume":"275","author":"BL Goode","year":"2000","unstructured":"Goode BL, Chau M, Denis PE, Feinstein SC (2000) Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenetative disease. J Biol Chem 275:38182\u201338189. https:\/\/doi.org\/10.1074\/jbc.M007489200","journal-title":"J Biol Chem"},{"key":"1189_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00401-013-1097-6","volume":"125","author":"M Hara","year":"2013","unstructured":"Hara M, Hirokawa K, Kamei S, Uchihara T (2013) Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology. Acta Neuropathol 125:565\u2013579. https:\/\/doi.org\/10.1007\/s00401-013-1097-6","journal-title":"Acta Neuropathol"},{"key":"1189_CR19","doi-asserted-by":"publisher","first-page":"e0195771","DOI":"10.1371\/journal.pone.0195771","volume":"13","author":"MM Hefti","year":"2018","unstructured":"Hefti MM, Farrell K, Kim S, Bowles KR, Fowkes ME, Raj T et al (2018) High-resolution temporal and regional mapping of MAPT expression and splicing in human brain development. PLoS ONE 13:e0195771. https:\/\/doi.org\/10.1371\/journal.pone.0195771","journal-title":"PLoS ONE"},{"key":"1189_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 8:1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimer's Dementia"},{"key":"1189_CR21","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/jnen\/61.12.1040","volume":"61","author":"T Ishizawa","year":"2002","unstructured":"Ishizawa T, Ko LW, Cookson N, Davias P, Espinoza M, Dickson DW (2002) Selective neurofibrillary degeneration of the hippocampal CA2 sector is associated with four-repeat tauopathies. J Neuropathol Exp Neurol 61:1040\u20131047. https:\/\/doi.org\/10.1093\/jnen\/61.12.1040","journal-title":"J Neuropathol Exp Neurol"},{"key":"1189_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fnagi.2020.00096","volume":"12","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG (2020) Astroglia and Tau: New Perspectives. Frontiers in aging neuroscience 12:96. https:\/\/doi.org\/10.3389\/fnagi.2020.00096","journal-title":"Frontiers in aging neuroscience"},{"key":"1189_CR23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","volume":"24","author":"A Leuzy","year":"2019","unstructured":"Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E et al (2019) Tau PET imaging in neurodegenerative tauopathies-still a challenge. Mol Psychiatry 24:1112\u20131134. https:\/\/doi.org\/10.1038\/s41380-018-0342-8","journal-title":"Mol Psychiatry"},{"key":"1189_CR24","doi-asserted-by":"publisher","first-page":"8173","DOI":"10.1074\/jbc.M115.641902","volume":"291","author":"C Liu","year":"2016","unstructured":"Liu C, Song X, Nisbet R, Gotz J (2016) Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease. J Biol Chem 291:8173\u20138188. https:\/\/doi.org\/10.1074\/jbc.M115.641902","journal-title":"J Biol Chem"},{"key":"1189_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1326-3-8","volume":"3","author":"F Liu","year":"2008","unstructured":"Liu F, Gong CX (2008) Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener 3:8. https:\/\/doi.org\/10.1186\/1750-1326-3-8","journal-title":"Mol Neurodegener"},{"key":"1189_CR26","doi-asserted-by":"publisher","DOI":"10.1201\/b22602","volume-title":"Greenfield\u2019s neuropathology","author":"S Love","year":"2008","unstructured":"Love S, Louis D, Ellison DW (2008) Greenfield\u2019s neuropathology, vol 2, 8th edn. CRC Press, Boca Raton, FL","edition":"8"},{"key":"1189_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119:1\u20134. https:\/\/doi.org\/10.1007\/s00401-009-0612-2","journal-title":"Acta Neuropathol"},{"key":"1189_CR28","doi-asserted-by":"publisher","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","volume":"2","author":"EM Mandelkow","year":"2012","unstructured":"Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2:a006247. https:\/\/doi.org\/10.1101\/cshperspect.a006247","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1189_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-015-1515-z","volume":"131","author":"AC McKee","year":"2015","unstructured":"McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Dirk Keene C, Litvan I et al (2015) The first NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol 131:75\u201386. https:\/\/doi.org\/10.1007\/s00401-015-1515-z","journal-title":"Acta Neuropathol"},{"key":"1189_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/brain\/aws307","volume":"136","author":"AC McKee","year":"2013","unstructured":"McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH et al (2013) The spectrum of disease in chronic traumatic encephalopathy. Brain 136:43\u201364. https:\/\/doi.org\/10.1093\/brain\/aws307","journal-title":"Brain"},{"key":"1189_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","volume":"9","author":"IG McKeith","year":"2006","unstructured":"McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9:417\u2013423","journal-title":"J Alzheimers Dis"},{"key":"1189_CR32","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cne.21867","volume":"511","author":"P McMillan","year":"2008","unstructured":"McMillan P, Korvatska E, Poorkaj P, Evstafjeva Z, Robinson L, Greenup L et al (2008) Tau isoform regulation is region- and cell-specific in mouse brain. J Comp Neurol 511:788\u2013803. https:\/\/doi.org\/10.1002\/cne.21867","journal-title":"J Comp Neurol"},{"key":"1189_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000365548","volume":"38","author":"I Milenkovic","year":"2014","unstructured":"Milenkovic I, Petrov T, Kovacs GG (2014) Patterns of hippocampal tau pathology differentiate neurodegenerative dementias. Dement Geriatr Cogn Disord 38:375\u2013388. https:\/\/doi.org\/10.1159\/000365548","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1189_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"1189_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00401-019-02031-x","volume":"138","author":"OJ Standring","year":"2019","unstructured":"Standring OJ, Friedberg J, Tripodis Y, Chua AS, Cherry JD, Alvarez VE et al (2019) Contact sport participation and chronic traumatic encephalopathy are associated with altered severity and distribution of cerebral amyloid angiopathy. Acta Neuropathol 138:401\u2013413. https:\/\/doi.org\/10.1007\/s00401-019-02031-x","journal-title":"Acta Neuropathol"},{"key":"1189_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00401-015-1435-y","volume":"130","author":"TD Stein","year":"2015","unstructured":"Stein TD, Montenigro PH, Alvarez VE, Xia W, Crary JF, Tripodis Y et al (2015) Beta-amyloid deposition in chronic traumatic encephalopathy. Acta Neuropathol 130:21\u201334. https:\/\/doi.org\/10.1007\/s00401-015-1435-y","journal-title":"Acta Neuropathol"},{"key":"1189_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00401-004-0842-2","volume":"107","author":"T Togo","year":"2004","unstructured":"Togo T, Akiyama H, Iseki E, Uchikado H, Kondo H, Ikeda K et al (2004) Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions. Acta Neuropathol 107:504\u2013508. https:\/\/doi.org\/10.1007\/s00401-004-0842-2","journal-title":"Acta Neuropathol"},{"key":"1189_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/neup.12669","volume":"40","author":"T Uchihara","year":"2020","unstructured":"Uchihara T (2020) Neurofibrillary changes undergoing morphological and biochemical changes - How does tau with the profile shift of from four repeat to three repeat spread in Alzheimer brain? Neuropathology 40:450\u2013459. https:\/\/doi.org\/10.1111\/neup.12669","journal-title":"Neuropathology"},{"key":"1189_CR39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/neup.12108","volume":"34","author":"T Uchihara","year":"2014","unstructured":"Uchihara T (2014) Pretangles and neurofibrillary changes: similarities and differences between AD and CBD based on molecular and morphological evolution. Neuropathology 34:571\u2013577. https:\/\/doi.org\/10.1111\/neup.12108","journal-title":"Neuropathology"},{"key":"1189_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/jnen\/nlaa153","volume":"80","author":"JM Walker","year":"2021","unstructured":"Walker JM, Richardson TE, Farrell K, Iida MA, Foong C, Shang P et al (2021) Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. J Neuropathol Exp Neurol 80:102\u2013111. https:\/\/doi.org\/10.1093\/jnen\/nlaa153","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 1","key":"1189_CR41","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.3233\/JAD-2012-129031","volume":"33","author":"JZ Wang","year":"2013","unstructured":"Wang JZ, Xia YY, Grundke-Iqbal I, Iqbal K (2013) Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 33(Suppl 1):S123-139. https:\/\/doi.org\/10.3233\/JAD-2012-129031","journal-title":"J Alzheimers Dis"},{"key":"1189_CR42","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","volume":"72","author":"MD Weingarten","year":"1975","unstructured":"Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72:1858\u20131862. https:\/\/doi.org\/10.1073\/pnas.72.5.1858","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1189_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","volume":"580","author":"W Zhang","year":"2020","unstructured":"Zhang W, Tarutani A, Newell KL, Murzin AG, Matsubara T, Falcon B et al (2020) Novel tau filament fold in corticobasal degeneration. Nature 580:283\u2013287. https:\/\/doi.org\/10.1038\/s41586-020-2043-0","journal-title":"Nature"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-021-01189-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-021-01189-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-021-01189-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T07:16:24Z","timestamp":1620803784000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-021-01189-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1186\/s40478-021-01189-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}